DTIL — PRECISION BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1357874 ·
Last close
$6.22
Market Cap
$171.68M
52W High
$9.62
52W Low
$3.53
ADV30
273,797
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -19,161,000 | -32,652,000 | 125,920,000 | 86,076,000 | 80,627,000 |
| Mar 2026 | 10,838,000 | — | -9,075,000 | -18,441,000 | 143,891,000 | 99,370,000 | 67,790,000 |
| Dec 2025 | 34,204,000 | — | 12,508,000 | 20,133,000 | 154,416,000 | 110,823,000 | 62,168,000 |
| Sep 2025 | 13,000 | — | -20,667,000 | -21,772,000 | 93,510,000 | 44,870,000 | 76,876,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-51,899,000
Investing CF
$-421,000
Financing CF
$79,920,000
CapEx
$-818,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.80
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-579,281,000
Inventory
—
Receivables
$0
ST Investments
$1,473,000
EBIT TTM
$-52,296,000
Pretax Income TTM
$-53,617,000
Interest Exp TTM
$1,321,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,055,000
EBITDA
$-35,148,000
Free Cash Flow
$-16,252,500
Enterprise Value
$138,455,136
Total Cash
$87,549,000
Total Debt
$28,101,000
Shares Out
27,601,554
Trailing EPS
$-1.32
Book Value
$1.71
ROE
-135.1%
ROA
-19.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,264,000 | -52,148,000 | -45,724,000 | 154,416,000 | 62,168,000 | 92,248,000 | -65,843,000 |
| Dec 2024 | 68,696,000 | -26,162,000 | 7,167,000 | 136,388,000 | 79,995,000 | 56,393,000 | -58,445,000 |
| Dec 2023 | 48,727,000 | -43,736,000 | -61,319,000 | 159,781,000 | 140,920,000 | 18,861,000 | -84,114,000 |
| Dec 2022 | 25,098,000 | -62,308,000 | -111,637,000 | 238,169,000 | 177,736,000 | 60,433,000 | -45,753,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.86
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $6.08 · call volume: 86 · put volume: 4
Expected Move to 2027-01-15:
±$4.65
(76.48%) —
implied range
$1.43 –
$10.73
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CHRS | Coherus Oncology, Inc. | $174.59M | $1.13 | — |
| VYGR | Voyager Therapeutics, Inc. | $165.14M | $2.68 | — |
| MOLN | MOLECULAR PARTNERS AG | $164.71M | $4.30 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $161.99M | $2.24 | — |
| IPHYF | Innate Pharma SA | $184.31M | $1.65 | — |
News headlines (Yahoo Finance, 1h cache)
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
2026-08-24 10:01 · Yahoo
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-06 11:01 · Yahoo
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-31 11:01 · Yahoo
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
2026-07-08 14:32 · Yahoo
Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 12:25 · Yahoo
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
2026-09-17 20:09 · Yahoo
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
2026-07-27 11:01 · Yahoo
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-07-10 11:01 · Yahoo
Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
2026-06-29 11:01 · Yahoo
Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?
2026-04-20 11:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.